| Date | Time | Source | Headline | Symbol | Company |
| 10/02/2007 | 6:01AM | Edgar (US Regulatory) | Aeterna Zentaris Inc. - Notice of Effectiveness (EFFECT) | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 10/02/2007 | 6:01AM | Edgar (US Regulatory) | Aeterna Zentaris Inc. - Notice of Effectiveness (EFFECT) | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 09/27/2007 | 3:25PM | Edgar (US Regulatory) | Aeterna Zentaris Inc. (Other) (F-10/A) | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 09/27/2007 | 7:30AM | PR Newswire (US) | AEterna Zentaris to Announce Outcome of Management's Strategic Review | NASDAQ:AEZS | |
| 09/26/2007 | 7:30AM | PR Newswire (US) | AEterna Zentaris to Present at Upcoming William Blair & Company Small-Cap Growth Stock Conference in New York and BioContact in | NASDAQ:AEZS | |
| 09/20/2007 | 7:30AM | PR Newswire (US) | AEterna Zentaris to Present at Upcoming UBS Global Life Sciences Conference in New York | NASDAQ:AEZS | |
| 09/19/2007 | 12:46PM | Edgar (US Regulatory) | Aeterna Zentaris Inc. (Other) | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 09/19/2007 | 12:29PM | Edgar (US Regulatory) | Aeterna Zentaris Inc. (Other) | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 09/19/2007 | 10:35AM | Edgar (US Regulatory) | Aeterna Zentaris Inc. (Other) | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 08/16/2007 | 7:30AM | PR Newswire (US) | AEterna Zentaris completes management team with the appointment of Chief Medical Officer | NASDAQ:AEZS | |
| 08/14/2007 | 7:15AM | PR Newswire (US) | Aeterna Zentaris appoints Jurgen Ernst Chairman of the Board of Directors and David J. Mazzo, Ph.D. a Board Member | NASDAQ:AEZS | |
| 08/14/2007 | 7:00AM | PR Newswire (US) | AEterna Zentaris Reports Second Quarter 2007 Financial and Operating Results | NASDAQ:AEZS | |
| 08/06/2007 | 8:30AM | PR Newswire (US) | AEterna Zentaris to Announce Second Quarter 2007 Financial and Operating Results on August 14, 2007 | NASDAQ:AEZS | |
| 08/02/2007 | 7:30AM | PR Newswire (US) | AEterna Zentaris to Present at Upcoming 27th Annual Canaccord Adams Global Growth Conference in Boston | NASDAQ:AEZS | |
| 07/10/2007 | 10:45AM | PR Newswire (US) | Lpath and Echelon Introduce New Cancer Research Assay Based on Lpath's Breakthrough Anti-Cancer Drug Candidate, Sphingomab(TM) | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 07/10/2007 | 9:45AM | PR Newswire (US) | Lpath and Echelon Introduce New Cancer Research Assay Based on Lpath's Breakthrough Anti-Cancer Drug Candidate, Sphingomab(TM) | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 06/29/2007 | 10:53AM | PR Newswire (US) | Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase II Data on KRX-0401 in Patients with Relapsed/Refractory Mul | NASDAQ:AEZS | |
| 06/04/2007 | 8:40AM | PR Newswire (US) | AEterna Zentaris Partner Keryx Presents Phase 1 and Phase 2 Results for Anti-Cancer Compound Perifosine at ASCO Meeting | NASDAQ:AEZS | |
| 06/04/2007 | 8:30AM | PR Newswire (US) | AEterna Zentaris Presents Detailed Phase 1 Results for Anti-Cancer Compound AEZS-108 at ASCO Meeting | NASDAQ:AEZS | |
| 05/23/2007 | 8:00AM | PR Newswire (US) | AEterna Zentaris' Partner, Spectrum, Discloses Detailed Phase 2 Data for Ozarelix, in BPH at Annual AUA Meeting | NASDAQ:AEZS | |
| 05/09/2007 | 8:30AM | PR Newswire (US) | AEterna Zentaris to Present at Upcoming Acumen BioFin Rodman & Renshaw 4th Annual Global Healthcare Conference in Monte Carlo, M | NASDAQ:AEZS | |
| 05/08/2007 | 8:30AM | PR Newswire (US) | AEterna Zentaris Regains Exclusive Worldwide (ex-Japan) Rights from Solvay for Cetrorelix in Endometriosis Indication | NASDAQ:AEZS | |
| 05/07/2007 | 8:30AM | PR Newswire (US) | AEterna Zentaris Bolsters Management Team with Two Key Positions Named | NASDAQ:AEZS | |
| 05/02/2007 | 8:30AM | PR Newswire (US) | AEterna Zentaris Reports First Quarter 2007 Financial and Operating Results | NASDAQ:AEZS | |
| 04/30/2007 | 8:30AM | PR Newswire (US) | AEterna Zentaris to Hold Annual Shareholder Meeting on May 2, 2007 at the Sheraton Centre in Montreal | NASDAQ:AEZS | |
| 04/25/2007 | 1:06PM | PR Newswire (US) | /C O R R E C T I O N from source - AEterna Zentaris Inc./ | NASDAQ:AEZS | |
| 04/25/2007 | 8:30AM | PR Newswire (US) | AEterna Zentaris to Announce First Quarter 2007 Financial and Operating Results on May 2, 2007 | NASDAQ:AEZS | |
| 04/25/2007 | 8:30AM | PR Newswire (US) | AEterna Zentaris to Announce First Quarter 2007 Financial and Operating Results on May 2, 2007 | NASDAQ:AEZS | |
| 04/19/2007 | 8:30AM | PR Newswire (US) | AEterna Zentaris Reports First Patients Treated with Cetrorelix for Phase 3 Program in BPH | NASDAQ:AEZS | |
| 04/19/2007 | 8:30AM | PR Newswire (US) | AEterna Zentaris Reports First Patients Treated with Cetrorelix for Phase 3 Program in BPH | NASDAQ:AEZS | |